{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:49:31Z","timestamp":1790851771826,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021821","name":"Oncode Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C38317\/A24043"],"award-info":[{"award-number":["C38317\/A24043"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ccell.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T10:46:18Z","timestamp":1682592378000},"page":"986-1002.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression"],"prefix":"10.1016","volume":"41","author":[{"given":"Stefan J.","family":"Hutten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roebi","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"Badoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Eijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ciwinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sheinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Messal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Herencia-Ropero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kristel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rens","family":"van der Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde M.","family":"Almekinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Llop-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs J.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel I.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Behbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Nik-Zainal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco","family":"van Rheenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther H.","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewyk F.A.","family":"Wessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colinda L.G.J.","family":"Scheele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-9792","authenticated-orcid":false,"given":"Jos","family":"Jonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2023.04.002_bib1","unstructured":"Netherlands Comprehensive Cancer Organisation. (2016). www.cijfersoverkanker.nl."},{"key":"10.1016\/j.ccell.2023.04.002_bib3","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ccell.2023.04.002_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in\u00a0situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/modpathol.2015.75","article-title":"Copy number analysis of ductal carcinoma in\u00a0situ with and without recurrence","volume":"28","author":"Gorringe","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib6","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-19-2563","article-title":"Whole-exome sequencing analysis of the progression from non\u2013low-grade ductal carcinoma in\u00a0situ to invasive ductal carcinoma","volume":"26","author":"Pareja","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-019-05401-x","article-title":"Genomic landscape of ductal carcinoma in\u00a0situ and association with progression","volume":"178","author":"Lin","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ccell.2023.04.002_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10911-018-9408-0","article-title":"Modeling human ductal carcinoma in\u00a0situ in the mouse","volume":"23","author":"Behbod","year":"2018","journal-title":"J.\u00a0Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.ccell.2023.04.002_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/path.2969","article-title":"Human primary ductal carcinoma in\u00a0situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model","volume":"225","author":"Valdez","year":"2011","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib10","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr2358","article-title":"An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in\u00a0situ","volume":"11","author":"Behbod","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib11","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.ajpath.2015.07.004","article-title":"Myoepithelial cell differentiation markers in ductal carcinoma in\u00a0situ progression","volume":"185","author":"Russell","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","article-title":"A preclinical model for ER\u03b1-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response","volume":"29","author":"Sflomos","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.04.002_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/path.5820","article-title":"Mouse-INtraDuctal (MIND): an in\u00a0vivo model for studying the underlying mechanisms of DCIS malignancy","volume":"256","author":"Hong","year":"2022","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of breast carcinoma: histological subtypes and clinical relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin. Med. Insights Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ccell.2022.10.021","article-title":"Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in\u00a0situ: analysis of TBCRC 038 and RAHBT cohorts","volume":"40","author":"Strand","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.04.002_bib16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","article-title":"Genomic analysis defines clonal relationships of ductal carcinoma in\u00a0situ and recurrent invasive breast cancer","volume":"54","author":"Lips","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.04.002_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm.4292","article-title":"HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures","volume":"23","author":"Davies","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.04.002_bib18","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Bernard","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.04.002_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13058-015-0520-4","article-title":"Molecular subtyping for clinically defined breast cancer subgroups","volume":"17","author":"Zhao","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in\u00a0situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccell.2023.04.002_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnci\/djq101","article-title":"Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in\u00a0situ diagnosis","volume":"102","author":"Kerlikowske","year":"2010","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccell.2023.04.002_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10549-016-3814-z","article-title":"Risk prediction for local versus regional\/metastatic tumors after initial ductal carcinoma in\u00a0situ diagnosis treated by lumpectomy","volume":"157","author":"Molinaro","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ccell.2023.04.002_bib23","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3892\/ol.2016.4134","article-title":"S100A8\/A9 is associated with estrogen receptor loss in breast cancer","volume":"11","author":"Bao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ccell.2023.04.002_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fonc.2018.00496","article-title":"Clinical significance of elevated S100A8 expression in breast cancer patients","volume":"8","author":"Wang","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2023.04.002_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbrc.2014.11.064","article-title":"FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27","volume":"456","author":"Zhao","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ccell.2023.04.002_bib26","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1093\/nar\/gkt845","article-title":"Identifying subgroup markers in heterogeneous populations","volume":"41","author":"de Ronde","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0594-z","article-title":"PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2\u00a0+ breast cancer cells by inducing Bim","volume":"17","author":"Park","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41523-017-0047-1","article-title":"ARTICLE OPEN PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells","volume":"3","author":"Ito","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41596-020-00414-z","article-title":"Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH","volume":"16","author":"Messal","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2023.04.002_bib30","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1245\/s10434-009-0533-2","article-title":"Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a hospital-based cohort study in Iowa","volume":"16","author":"Lal","year":"2009","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ccell.2023.04.002_bib31","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.18632\/oncotarget.3162","article-title":"Genomic differences between pure ductal carcinoma in\u00a0situ and synchronous ductal carcinoma in\u00a0situ with invasive breast cancer","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2023.04.002_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2017.12.007","article-title":"Multiclonal invasion in breast tumors identified by topographic single cell sequencing","volume":"172","author":"Casasent","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.04.002_bib33","doi-asserted-by":"crossref","first-page":"1185a","DOI":"10.1093\/jnci\/92.14.1185a","article-title":"MCF10DCIS.com xenograft model of human comedo ductal carcinoma in\u00a0situ","volume":"92","author":"Miller","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccell.2023.04.002_bib34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/sj.bjc.6695007","article-title":"Molecular cytogenetic analysis of 11 new breast cancer cell lines","volume":"81","author":"Forozan","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib35","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/modpathol.2017.21","article-title":"Breast ductal carcinoma in\u00a0situ carry mutational driver events representative of invasive breast cancer","volume":"30","author":"Pang","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","article-title":"Genomic analysis defines clonal relationships of ductal carcinoma in\u00a0situ and recurrent invasive breast cancer","volume":"54","author":"Lips","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.04.002_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological markers in DCIS and risk of breast recurrence: a systematic review","volume":"2","author":"Lari","year":"2011","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib38","series-title":"Ductal Carcinoma in Situ and Microinvasive\/borderline Breast Cancer","author":"Newman","year":"2015"},{"key":"10.1016\/j.ccell.2023.04.002_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1055-9965.EPI-18-0976","article-title":"Predictors of an invasive breast cancer recurrence after DCIS: a systematic review and meta-analyses","volume":"28","author":"Visser","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ccell.2023.04.002_bib40","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/1078-0432.CCR-21-1239","article-title":"Prognostic and predictive value of HER2 expression in ductal carcinoma in situ : results from the UK\/ANZ DCIS randomized trial","volume":"27","author":"Thorat","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib41","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/1055-9965.EPI-08-1101","article-title":"HER-2\/neu overexpression as a predictor for the transition from in situ to invasive breast cancer","volume":"18","author":"Roses","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ccell.2023.04.002_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prp.2010.08.005","article-title":"HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in\u00a0situ of the breast presenting extensive DCIS component","volume":"207","author":"Liao","year":"2011","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ccell.2023.04.002_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12885-015-1479-3","article-title":"The prognostic role of HER2 expression in ductal breast carcinoma in\u00a0situ (DCIS); a population-based cohort study","volume":"15","author":"Borgquist","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyx059","article-title":"Current approach and future perspective for ductal carcinoma in\u00a0situ of the breast","volume":"47","author":"Kanbayashi","year":"2017","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.04.002_bib45","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in\u00a0situ - the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib46","doi-asserted-by":"crossref","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in\u00a0situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ccell.2023.04.002_bib47","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","article-title":"Breast cancer precursors revisited: molecular features and progression pathways","volume":"57","author":"Lopez-Garcia","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.ccell.2023.04.002_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41551-020-00681-x","article-title":"Harnessing non-destructive 3D pathology","volume":"5","author":"Liu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ccell.2023.04.002_bib50","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41568-021-00382-w","article-title":"Tissue clearing to examine tumour complexity in three dimensions","volume":"21","author":"Almagro","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib51","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1158\/0008-5472.CAN-08-2660","article-title":"PIK3CA mutations in in\u00a0situ and invasive breast carcinomas","volume":"70","author":"Miron","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nm.3886","article-title":"Subclonal diversification of primary breast cancer revealed by multiregion sequencing","volume":"21","author":"Yates","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.04.002_bib53","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.3990","article-title":"Genomic and mutational profiling of ductal carcinomas in\u00a0situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection","volume":"227","author":"Hernandez","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccell.2023.04.002_bib54","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.18632\/oncotarget.3111","article-title":"Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis","volume":"6","author":"Kr\u00f8ig\u00e5rd","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2023.04.002_bib55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in\u00a0situ to invasive breast cancer: revisited","volume":"7","author":"Cowell","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ccell.2023.04.002_bib56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nm.4279","article-title":"Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples","volume":"23","author":"Martelotto","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.04.002_bib57","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","article-title":"Immune escape in breast cancer during in situ to invasive carcinoma transition","volume":"7","author":"Gil Del Alcazar","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2023.04.002_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","article-title":"Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma","volume":"185","author":"Risom","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.04.002_bib59","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.201700740R","article-title":"Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy","volume":"32","author":"Wang","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.ccell.2023.04.002_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40425-019-0518-z","article-title":"Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts","volume":"7","author":"Capasso","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2023.04.002_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. j."},{"key":"10.1016\/j.ccell.2023.04.002_bib62","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib63","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.12688\/f1000research.10082.2","article-title":"Disambiguate: an open-source application for disambiguating two species in next generation sequencing data from grafted samples","volume":"5","author":"Ahdesm\u00e4ki","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib64","author":"Andrews"},{"key":"10.1016\/j.ccell.2023.04.002_bib65","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib66","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib67","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1101\/gr.175141.114","article-title":"DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly","volume":"24","author":"Scheinin","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib68","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1093\/bioinformatics\/bty350","article-title":"Snakemake\u2014a scalable bioinformatics workflow engine","volume":"34","author":"K\u00f6ster","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib69","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2023.04.002_bib70","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2023.04.002_bib72","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2023.04.002_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib74","doi-asserted-by":"crossref","first-page":"15.10.1","DOI":"10.1002\/cpbi.20","article-title":"cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data","volume":"56","author":"Jones","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib75","doi-asserted-by":"crossref","first-page":"15.7.1","DOI":"10.1002\/0471250953.bi1507s52","article-title":"cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing","volume":"52","author":"Raine","year":"2015","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ccell.2023.04.002_bib76","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdy099","article-title":"RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer","volume":"29","author":"Cruz","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2023.04.002_bib77","doi-asserted-by":"crossref","first-page":"e9172","DOI":"10.15252\/emmm.201809172","article-title":"A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation","volume":"10","author":"Castroviejo-Bermejo","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ccell.2023.04.002_bib78","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1158\/0008-5472.CAN-21-2409","article-title":"Preclinical in\u00a0vivo validation of the RAD51 test for identification of homologous recombination-deficient tumors and patient stratification","volume":"82","author":"Pellegrino","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.04.002_bib79","author":"De Ronde"},{"key":"10.1016\/j.ccell.2023.04.002_bib80","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2023.04.002_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823001289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823001289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:11:07Z","timestamp":1761523867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610823001289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1535610823001289"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2023.04.002","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}